Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future treatment strategies for COPD.

Mitchell Friedman1

  • 1Section of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.

Clinical Cornerstone
|May 13, 2003
PubMed
Summary

Chronic obstructive pulmonary disease (COPD) is a major cause of death, characterized by inflammation and airflow limitation. This review explores current and emerging therapeutic targets for COPD management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Developmental Toxicity of Vedolizumab, an α<sub>4</sub>β<sub>7</sub> Receptor Antagonist, in Rabbit and Nonhuman Primate.

International journal of toxicology·2019
Same author

Activation of transcription factor IL-6 (NF-IL-6) and nuclear factor-kappaB (NF-kappaB) by lipid ozonation products is crucial to interleukin-8 gene expression in human airway epithelial cells.

Environmental toxicology·2007
Same author

Gene expression profiling in mouse lung following polymeric hexamethylene diisocyanate exposure.

Toxicology and applied pharmacology·2005
Same author

Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage.

Clinical cancer research : an official journal of the American Association for Cancer Research·2004
Same author

Successful bronchoscopic balloon dilation of nonmalignant tracheobronchial obstruction without fluoroscopy.

Chest·2004
Same author

Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).

PharmacoEconomics·2004

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Inflammation Research

Background:

  • Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the US.
  • COPD is defined as a progressive disease with chronic respiratory inflammation and airflow limitation.
  • The cellular and molecular mechanisms of COPD pathogenesis are increasingly studied.

Purpose of the Study:

  • To review major therapeutic targets for COPD.
  • To identify currently available treatment agents.
  • To discuss novel agents under development for COPD.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of current treatment guidelines.
  • Examination of preclinical and clinical research on new COPD therapies.

Main Results:

  • Established therapeutic targets include bronchodilators and anti-inflammatory agents.
  • Current treatments focus on symptom management and exacerbation prevention.
  • Emerging therapies target specific inflammatory pathways and cellular processes.

Conclusions:

  • Understanding COPD pathogenesis is key to developing new treatments.
  • A range of therapeutic options exist, with ongoing research for improved strategies.
  • Future therapies aim for more targeted and effective COPD management.

Related Experiment Videos